Abstract: A sealing element is formed from a desirably shaped body of a sealant material formulated from a first polymer in a concentration of about 25 percent to about 40 percent, an inert filler material in a concentration of about 20 percent to about 45 percent and a hydrocarbon resin in a concentration of about 1 percent to about 15 percent. The sealant material, when positioned about a first component is overmolded with a material forming a second component. The sealant material, which is heat activated, forms a seal between the first and second components.

Abstract: A sealing element is formed from a desirably shaped body of a sealant material formulated from a first polymer, ethylene vinyl acetate (EVA), in a concentration of about 25 percent to about 30 percent, a calcium carbonate inert filler material in a concentration of about 25 percent to about 30 percent, a second ethylene polymer other than EVA in a concentration of about 20 to about 35 percent, and a hydrocarbon resin in a concentration of about 10 percent to about 15 percent. The sealant further comprising an epoxy resin in a concentration of about 2 to about 5 percent and an activator in a concentration of about less than one percent of the sealant. The sealant material, when positioned about a first component is overmolded with a material forming a second component. The sealant material, which is heat activated, forms a seal between the first and second components.

Abstract: A Conveyorable Plastic Thermoformed Pallet, having a support member and support legs with outer walls, internal walls and inner walls, is utilized to transport product on a conveyor system. The Pallet is made using a twin-sheet thermoforming process that requires two molds for an upper sheet of thermoplastic material and a lower sheet of thermoplastic material. The upper sheet forms a top deck of the support member and the internal walls of the support legs. The lower sheet forms the underside of the support member, the inner walls of the support legs, and leg bottoms. Both sheets are fused to form the twin-sheet outer walls. The upper sheet also forms web strips which stabilize the walls of the support legs and prevent deflection of the walls.

Abstract: A Conveyorable Plastic Thermoformed Pallet, having a support member and support legs with outer walls, internal walls and inner walls, is utilized to transport product on a conveyor system. The Pallet is made using a twin-sheet thermoforming process that requires two molds for an upper sheet of thermoplastic material and a lower sheet of thermoplastic material. The upper sheet forms a top deck of the support member and the internal walls of the support legs. The lower sheet forms the underside of the support member, the inner walls of the support legs, and leg bottoms. Both sheets are fused to form the twin-sheet outer walls. The upper sheet also forms web strips which stabilize the walls of the support legs and prevent deflection of the walls.

Abstract: A sealing element is formed from a desirably shaped body of a sealant material formulated from a first polymer in a concentration of about 25 percent to about 40 percent, an inert filler material in a concentration of about 20 percent to about 45 percent and a hydrocarbon resin in a concentration of about 1 percent to about 15 percent. The sealant material, when positioned about a first component is overmolded with a material forming a second component. The sealant material, which is heat activated, forms a seal between the first and second components.

Abstract: Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of protein tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.

Abstract: Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of proteins tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.

Abstract: Aryl, alkyl, alkenyl and alkynyl macrolides of the general structural Formula I: ##STR1## have been prepared from suitable precursors by modification at C-30, C-33, and/or C-34 of the cyclohexyl ring. These macrolide immunosuppressants are useful in a mammalian host for the treatment of autoimmune diseases, infectious diseases and/or the prevention of rejection of foreign organ transplants and/or related afflictions, diseases and illnesses.

Abstract: Alkyl and alkenyl macrolides of the general structural Formula I: ##STR1## have been prepared from suitable precursors by oxidation and derivitization at C-17. These macrolide immunosuppressants are useful in a mammalian host for the treatment of autoimmune diseases, infectious diseases and/or the prevention of rejection of foreign organ transplants. In addition, these macrolide immunosuppressants are useful in the topical treatment of inflammatory and hyperproliferative skin diseases and cutaneous manifestations of immunologically-mediated illnesses.

Abstract: Returning red blood cells to a patient after a centrifuge separation procedure by connecting an inflow line of a separation channel to an outflow line to provide a closed loop and recirculating liquid through it to remove blood cells. Also disclosed is pulling more liquid out of a flexible separation channel than permitted into it in order to reduce the volume of liquid to be used in returning cells to the patient.

Abstract: A therapeutic device for removing pathological effectors brom body fluids of a patient is disclosed. Said device includes a chamber for receiving the body fluids and positioned within the chamber is a biospecific polymer. Said biospecific polymer interacts with and binds specific pathological effectors carried by the body fluid that is passed through the chamber.